Delic’s (OTC: DELCF) Acquisition Target, Complex Biotech Discovery Ventures Ltd., Announces Hire of New Lead Chemist, Dr. Eric Janusson
VANCOUVER, BC, April 28, 2021 – Delic Holdings Inc. (“DELIC” or the “Company“) (CSE: DELC) (OTCQB: DELCF), a psychedelic wellness-focused company, is pleased to announce that its acquisition target, Complex Biotech Discovery Ventures Ltd. (“CBDV”), a licensed […]